Nelson Vergel
Founder, ExcelMale.com
Curated by Nelson Vergel | ExcelMale.com | Updated June 2026
If you have been on testosterone replacement therapy (TRT) for any length of time, you have probably noticed that your joints feel better, your chronic aches have softened, or your C-reactive protein (CRP) levels have come down since your testosterone levels normalized. That is not a coincidence. Testosterone is far more than a reproductive and anabolic hormone. It is one of the most powerful regulators of immune function in the human body - and new research is revealing just how deep that regulation runs.
Most people think of testosterone in terms of muscle, libido, and energy. But every neutrophil, monocyte, and T-cell in your body carries androgen receptors. That means testosterone is actively talking to your immune system right now, and the message it sends has enormous implications for your risk of autoimmune diseases, your susceptibility to infections, your response to vaccines, and your long-term joint health.
This article breaks down the science in plain language - from the specific molecular mechanism that lets testosterone physically block inflammation, to why low testosterone is an independent risk factor for both osteoarthritis and rheumatoid arthritis.
The answer lies in how testosterone - and estrogen - tune immune reactivity in opposite directions.
Estrogen acts as an immunostimulatory molecule. It enhances macrophage activity, accelerates antibody production, and amplifies T-cell proliferation. This makes women faster at clearing pathogens and generating robust vaccine responses - but it also creates a high-sensitivity environment where the immune system is more likely to misidentify the body's own tissues as threats.
Testosterone and its more potent form, 5-alpha-dihydrotestosterone (5-alpha-DHT), act as immunoinhibitory molecules. They dampen neutrophil and monocyte reactivity, reduce pro-inflammatory signaling, and increase regulatory T-cell populations - effectively keeping the immune system in a quieter, more controlled state.
This biological tradeoff means that men are less prone to self-attack but more vulnerable to persistent infections. At physiologic levels, this balance is protective. When testosterone falls below optimal levels, the suppressive effect is lost - and the immune system can become more reactive, raising the risk of chronic inflammation and joint destruction.
The key target is an enzyme system called the 5-LOX/FLAP complex. Here is how the process normally works:
• When an immune cell - say, a neutrophil or monocyte - detects an inflammatory trigger, the enzyme 5-lipoxygenase (5-LOX) migrates toward the nuclear membrane.
• At the membrane, 5-LOX docks with a protein called FLAP (5-LOX-activating protein).
• This assembled complex converts arachidonic acid into leukotrienes - potent lipid molecules that drive tissue swelling, recruit more immune cells, and sustain the inflammatory response.
Now here is what testosterone does to that sequence. When 5-alpha-DHT binds to androgen receptors on immune cells, it triggers rapid phosphorylation of ERK-1/2 (extracellular signal-regulated kinase). This sets off a chain reaction:
• In neutrophils, ERK-1/2 activation alters where 5-LOX sits inside the cell, placing it in a pre-translocated but functionally inactive state.
• In monocytes, testosterone also suppresses an enzyme called Phospholipase D (PLD), which reduces the formation of diacylglycerol (DAG) - the critical co-activator that allows 5-LOX to dock properly with FLAP.
• Without sufficient DAG, 5-LOX never successfully assembles with FLAP, and leukotriene production is blocked at the source.
Think of it this way: 5-LOX is the key and FLAP is the ignition. Testosterone keeps them from ever meeting. The inflammatory machinery is present but permanently separated, and the result is a baseline reduction in leukotriene production that helps explain why men with healthy testosterone levels rarely develop the chronic inflammatory joint conditions that affect so many people with low androgen status.
The findings showed that men and women in the highest quartile of testosterone levels had a 51% lower risk of developing arthritis compared to those in the lowest quartile. The risk reduction is not binary - it follows a gradient: the second quartile showed a 15% lower risk, the third quartile a 47% lower risk, and the highest quartile achieved that 51% threshold.
For rheumatoid arthritis (RA) specifically, the numbers are even more sobering. Men with testosterone below 300 ng/dL are 130% more likely to develop RA, with an odds ratio of 2.30. Multiple studies have also found that testosterone levels often fall below optimal ranges before RA symptoms become clinically apparent - meaning low testosterone may actually serve as an early biomarker for impending joint disease, not just a consequence of it.
Low testosterone is also associated with an odds ratio of 1.22 for osteoarthritis (OA), which is driven primarily by the loss of testosterone's bone and cartilage-protective effects. When testosterone falls, osteoclasts - the cells that resorb bone - become more active because testosterone normally suppresses the RANKL signaling molecule that drives them. Simultaneously, the conversion of testosterone into estradiol via aromatase provides secondary cartilage protection by stimulating proteoglycan production in joint tissue. Remove the testosterone, and both mechanisms fail.
Fat tissue - specifically white adipose tissue (WAT) - contains high concentrations of an enzyme called aromatase, which converts testosterone into estradiol. While some estradiol is necessary and beneficial (particularly for joint and bone health), excessive aromatization depletes the testosterone pool. Here is how the cycle runs:
• Excess body fat increases aromatase activity, converting testosterone into estrogen at an accelerated rate.
• Lower testosterone levels reduce muscle-building capacity and insulin sensitivity, making it harder to lose fat - which adds more aromatase to the system.
• Aging independently raises sex hormone-binding globulin (SHBG), which binds tightly to circulating testosterone and further reduces the biologically active free fraction.
• With testosterone depleted, the 5-LOX/FLAP complex assembles more freely in immune cells, driving up leukotriene and cytokine production (TNF-alpha, IL-1-beta, IL-6).
• These pro-inflammatory signals attack joint tissue, accelerate chondrocyte death, and stimulate RANKL-driven bone resorption.
• Joint pain and immobility reduce physical activity, which lowers testosterone further and increases fat mass.
This is why clinical testosterone measurements in obese men can be misleading. A "normal" total testosterone reading may mask dramatically low free and bioavailable testosterone once SHBG binding and aromatization are factored in. Men with symptoms of inflammation and joint pain should always have their free testosterone, estradiol, SHBG, and CRP evaluated together - not just total testosterone in isolation.
In men with hypogonadism and rheumatoid arthritis, testosterone therapy has been shown to reduce joint tenderness, morning stiffness, and levels of the inflammatory cytokines TNF-alpha and IL-1-beta. These changes are not merely the result of feeling better; they reflect measurable shifts in immune cell behavior driven by androgen receptor signaling.
More recently, a landmark 2024 study published in Nature examined immune system changes in individuals undergoing gender-affirming testosterone therapy. The research found that testosterone modulates a cross-regulated axis between type-I interferon and tumor necrosis factor signaling - confirming that androgen-driven immune regulation is real, measurable, and occurs rapidly after testosterone levels rise.
In the context of TRT for hypogonadal men, many community members at ExcelMale.com report that their aches and chronic inflammation improved noticeably within the first months of treatment. This is consistent with what the research predicts: as testosterone levels normalize, the 5-LOX/FLAP suppression pathway is re-engaged, cytokine production falls, and the joint environment becomes less destructive.
It is worth noting that estradiol balance matters too. Testosterone alone does not protect joints - it must also aromatize adequately to estradiol to maintain cartilage proteoglycan production and synovial fluid health. Men who use aromatase inhibitors aggressively often develop worsening joint pain precisely because they remove the estradiol that testosterone was generating. The goal is hormonal balance, not suppression.
Related ExcelMale Forum Discussions
• Investigating the Effects of Testosterone on the Human Immune System - Research discussion and video presentation by Dr. Camila Consiglio on how testosterone rewires immune signaling, including sex-based differences in vaccine response.
• How Testosterone Levels Impact Men's Immunity: New Research Uncovers Sex Differences in Infection and Cancer Risk - Forum thread reviewing 2025 research on testosterone, immune cell abundance, and differential disease susceptibility between men and women.
• Sex Hormone Signaling and Regulation of Immune Function - Deep-dive discussion on the molecular pathways through which sex hormones regulate innate and adaptive immunity, with links to peer-reviewed literature.
• Autoimmune Disease in Relation to Testosterone - Member experiences linking low testosterone to the onset and progression of autoimmune conditions, including Crohn's disease and inflammatory bowel disease.
• Does Testosterone Suppress the Immune System? - Classic ExcelMale thread examining whether TRT-level testosterone meaningfully suppresses immune function, with community perspectives and reference links.
• Why Does Low Estradiol Cause Joint Pain in Men on TRT? - Comprehensive guide explaining how aggressive aromatase inhibitor use strips cartilage-protective estradiol from TRT men, driving joint deterioration and elevated CRP.
• Does Low Estradiol Cause Joint Pain in Men Because of Inflammation? - Community thread with Nelson Vergel's input on the role of both low testosterone and low estradiol in driving CRP elevation and joint aching.
• TRT (Testosterone Replacement) and COVID-19 Vaccine - Member discussion on whether TRT affects vaccine immune responses, with references to androgen modulation of antibody production.
• Deca (Nandrolone) for Joint Pain - Community experiences using low-dose nandrolone as an adjunct for joint pain management in hypogonadal men, including safety and dosing considerations.
• Nagging, Persistent Joint Pain on TRT - Forum thread where members troubleshoot unexplained joint pain on TRT, including discussions of cortisol, inflammatory markers, and hormonal balance.
Key References
1. Cheng L, Wang S. Lower serum testosterone is associated with increased likelihood of arthritis. Scientific Reports. 2023;13:19033. Link
2. Consiglio CR, et al. Immune system adaptation during gender-affirming testosterone treatment. Nature. 2024. Link
3. Panevin TS, et al. Clinical and laboratory features of rheumatoid arthritis in men depending on testosterone levels. Problems of Endocrinology. 2023. Link
4. Poole JA, et al. Combined repetitive inhalant endotoxin and collagen-induced arthritis drive inflammatory lung disease and arthritis severity in a testosterone-dependent manner. Am J Physiol Lung Cell Mol Physiol. 2023. Link
5. Cutolo M, Straub RH. Sex steroids and autoimmune rheumatic diseases: state of the art. Nat Rev Rheumatol. 2020;16:628-644. Link
6. Liao Q, et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020;588:315-320. Link
7. Angele MK, et al. Testosterone and immune function. Critical Care Medicine. 2020. Link
8. Harding AT, Heaton NS. The impact of estrogens and their receptors on immunity and inflammation during infection. Cancers (Basel). 2022;14(4):909. Link
9. Pergola C, et al. Androgens suppress 5-lipoxygenase activation in polymorphonuclear leukocytes. FASEB J. 2011;25(8):2832-2842. Link
10. Capellino S, Claus M, Watzl C. Regulation of natural killer cell activity by glucocorticoids, sex hormones and prolactin. Endocr Connect. 2020;9(4):R19-R34. Link
For men with low testosterone, this regulatory function is impaired. Joints become more vulnerable to inflammatory destruction, the risk of rheumatoid arthritis rises dramatically, and the obesity-testosterone cycle can accelerate the entire process. Achieving and maintaining physiologically appropriate testosterone levels - not just "within reference range" but in the range where these anti-inflammatory effects are active - is a meaningful strategy for long-term musculoskeletal and immune health.
If you are dealing with joint pain, elevated CRP, or unexplained inflammation alongside symptoms of low testosterone, consider discussing a comprehensive hormone panel with your physician. For further reading, explore our guides on understanding your blood test results on TRT and SHBG: how it controls free testosterone and what to do about it.
Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting or modifying any hormone therapy or medical treatment. Individual results vary and depend on many factors including baseline health, co-existing conditions, and specific treatment protocols.
About ExcelMale.com
ExcelMale.com is the most trusted, expert-moderated men's health community on the internet, with over 24,000 members and more than 20 years of archived discussions on testosterone replacement therapy, hormone optimization, peptides, sexual health, and longevity. Founded by Nelson Vergel - chemical engineer, 34+ year TRT patient, and patient advocate - ExcelMale bridges the gap between clinical research and real-world male health. Nelson is the author of
Testosterone: A Man's Guide and Beyond Testosterone, both available on Amazon. Visit ExcelMale.com to join the community, access free hormone calculators, and find a TRT-knowledgeable physician through our doctor finder.
If you have been on testosterone replacement therapy (TRT) for any length of time, you have probably noticed that your joints feel better, your chronic aches have softened, or your C-reactive protein (CRP) levels have come down since your testosterone levels normalized. That is not a coincidence. Testosterone is far more than a reproductive and anabolic hormone. It is one of the most powerful regulators of immune function in the human body - and new research is revealing just how deep that regulation runs.
Most people think of testosterone in terms of muscle, libido, and energy. But every neutrophil, monocyte, and T-cell in your body carries androgen receptors. That means testosterone is actively talking to your immune system right now, and the message it sends has enormous implications for your risk of autoimmune diseases, your susceptibility to infections, your response to vaccines, and your long-term joint health.
This article breaks down the science in plain language - from the specific molecular mechanism that lets testosterone physically block inflammation, to why low testosterone is an independent risk factor for both osteoarthritis and rheumatoid arthritis.
| Key Takeaways |
| • Testosterone acts as a natural immunosuppressant, reducing the production of pro-inflammatory leukotrienes and cytokines through a rapid non-genomic signaling pathway. • Men with testosterone in the highest quartile have a 51% lower risk of developing arthritis compared to men in the lowest quartile (NHANES data, 2023). • Men with testosterone below 300 ng/dL are 130% more likely to develop rheumatoid arthritis, with an odds ratio of 2.30. • Testosterone works by physically preventing the assembly of the 5-LOX/FLAP inflammatory complex - the enzyme machinery that produces leukotrienes in immune cells. • Obesity worsens this picture by converting testosterone into estrogen via aromatase in fat tissue, while simultaneously raising pro-inflammatory markers like CRP and TNF-alpha. • Men on TRT who achieve physiologic testosterone levels typically see improvements in joint pain, inflammation markers, and musculoskeletal function. |
Why Do Men and Women Experience Immunity So Differently?
Here is a paradox that most doctors never explain: women mount stronger immune responses to infections and vaccines, yet they account for roughly 80 to 90 percent of all autoimmune disease cases. Men, meanwhile, tend to recover from viral infections more slowly and produce lower antibody titers after vaccination - yet they are far less likely to develop conditions like rheumatoid arthritis, lupus, or multiple sclerosis.The answer lies in how testosterone - and estrogen - tune immune reactivity in opposite directions.
Estrogen acts as an immunostimulatory molecule. It enhances macrophage activity, accelerates antibody production, and amplifies T-cell proliferation. This makes women faster at clearing pathogens and generating robust vaccine responses - but it also creates a high-sensitivity environment where the immune system is more likely to misidentify the body's own tissues as threats.
Testosterone and its more potent form, 5-alpha-dihydrotestosterone (5-alpha-DHT), act as immunoinhibitory molecules. They dampen neutrophil and monocyte reactivity, reduce pro-inflammatory signaling, and increase regulatory T-cell populations - effectively keeping the immune system in a quieter, more controlled state.
This biological tradeoff means that men are less prone to self-attack but more vulnerable to persistent infections. At physiologic levels, this balance is protective. When testosterone falls below optimal levels, the suppressive effect is lost - and the immune system can become more reactive, raising the risk of chronic inflammation and joint destruction.
| Immune Parameter | Higher Testosterone (Men) | Lower Testosterone / Women |
| Autoimmune disease risk | Low - androgen suppression protective | High - up to 90% bias in lupus (SLE) |
| Vaccine antibody response | Reduced - lower titer production | Robust - often 2x higher titers |
| Infection recovery speed | Slower - more susceptible to persistence | Faster - rapid pathogen clearance |
| Leukotriene production | Suppressed via 5-LOX/FLAP decoupling | Active - high inflammatory drive |
| CRP / TNF-alpha levels | Lower at physiologic T levels | Variable; higher at low-T states in men |
How Does Testosterone Physically Block Inflammation at the Cellular Level?
This is where the science gets genuinely fascinating - and where testosterone's role as an immune regulator becomes undeniable. Testosterone does not simply modulate gene expression over hours. It can shut down inflammatory machinery within minutes through what researchers call a non-genomic signaling pathway.The key target is an enzyme system called the 5-LOX/FLAP complex. Here is how the process normally works:
• When an immune cell - say, a neutrophil or monocyte - detects an inflammatory trigger, the enzyme 5-lipoxygenase (5-LOX) migrates toward the nuclear membrane.
• At the membrane, 5-LOX docks with a protein called FLAP (5-LOX-activating protein).
• This assembled complex converts arachidonic acid into leukotrienes - potent lipid molecules that drive tissue swelling, recruit more immune cells, and sustain the inflammatory response.
Now here is what testosterone does to that sequence. When 5-alpha-DHT binds to androgen receptors on immune cells, it triggers rapid phosphorylation of ERK-1/2 (extracellular signal-regulated kinase). This sets off a chain reaction:
• In neutrophils, ERK-1/2 activation alters where 5-LOX sits inside the cell, placing it in a pre-translocated but functionally inactive state.
• In monocytes, testosterone also suppresses an enzyme called Phospholipase D (PLD), which reduces the formation of diacylglycerol (DAG) - the critical co-activator that allows 5-LOX to dock properly with FLAP.
• Without sufficient DAG, 5-LOX never successfully assembles with FLAP, and leukotriene production is blocked at the source.
Think of it this way: 5-LOX is the key and FLAP is the ignition. Testosterone keeps them from ever meeting. The inflammatory machinery is present but permanently separated, and the result is a baseline reduction in leukotriene production that helps explain why men with healthy testosterone levels rarely develop the chronic inflammatory joint conditions that affect so many people with low androgen status.
What Does Low Testosterone Have to Do With Arthritis Risk?
The clinical data here is striking and underappreciated in mainstream medicine. A 2023 study using the National Health and Nutrition Examination Survey (NHANES) - one of the largest population-based health databases in the United States - found a dose-dependent relationship between serum testosterone and arthritis risk across 10,439 adults.The findings showed that men and women in the highest quartile of testosterone levels had a 51% lower risk of developing arthritis compared to those in the lowest quartile. The risk reduction is not binary - it follows a gradient: the second quartile showed a 15% lower risk, the third quartile a 47% lower risk, and the highest quartile achieved that 51% threshold.
For rheumatoid arthritis (RA) specifically, the numbers are even more sobering. Men with testosterone below 300 ng/dL are 130% more likely to develop RA, with an odds ratio of 2.30. Multiple studies have also found that testosterone levels often fall below optimal ranges before RA symptoms become clinically apparent - meaning low testosterone may actually serve as an early biomarker for impending joint disease, not just a consequence of it.
Low testosterone is also associated with an odds ratio of 1.22 for osteoarthritis (OA), which is driven primarily by the loss of testosterone's bone and cartilage-protective effects. When testosterone falls, osteoclasts - the cells that resorb bone - become more active because testosterone normally suppresses the RANKL signaling molecule that drives them. Simultaneously, the conversion of testosterone into estradiol via aromatase provides secondary cartilage protection by stimulating proteoglycan production in joint tissue. Remove the testosterone, and both mechanisms fail.
| Condition | Testosterone-Related Risk Data |
| Arthritis (general) | 51% lower risk in highest testosterone quartile vs. lowest (NHANES, 2023) |
| Rheumatoid Arthritis (RA) | 130% higher risk when testosterone is below 300 ng/dL; odds ratio 2.30 |
| Osteoarthritis (OA) | Odds ratio 1.22 for OA with testosterone deficiency |
| CRP elevation | Low testosterone and low estradiol both independently raise CRP levels |
| Bone density loss | Testosterone suppresses RANKL; deficiency accelerates osteoclast-driven bone resorption |
| Cartilage integrity | Testosterone-to-estradiol conversion sustains proteoglycan production; falls with low T |
How Does the Obesity-Testosterone Cycle Accelerate Joint Destruction?
One of the most clinically important dynamics in aging men is the self-reinforcing loop between body fat, testosterone, and joint inflammation. Understanding this cycle is crucial because it helps explain why two men of the same age can have dramatically different musculoskeletal outcomes.Fat tissue - specifically white adipose tissue (WAT) - contains high concentrations of an enzyme called aromatase, which converts testosterone into estradiol. While some estradiol is necessary and beneficial (particularly for joint and bone health), excessive aromatization depletes the testosterone pool. Here is how the cycle runs:
• Excess body fat increases aromatase activity, converting testosterone into estrogen at an accelerated rate.
• Lower testosterone levels reduce muscle-building capacity and insulin sensitivity, making it harder to lose fat - which adds more aromatase to the system.
• Aging independently raises sex hormone-binding globulin (SHBG), which binds tightly to circulating testosterone and further reduces the biologically active free fraction.
• With testosterone depleted, the 5-LOX/FLAP complex assembles more freely in immune cells, driving up leukotriene and cytokine production (TNF-alpha, IL-1-beta, IL-6).
• These pro-inflammatory signals attack joint tissue, accelerate chondrocyte death, and stimulate RANKL-driven bone resorption.
• Joint pain and immobility reduce physical activity, which lowers testosterone further and increases fat mass.
This is why clinical testosterone measurements in obese men can be misleading. A "normal" total testosterone reading may mask dramatically low free and bioavailable testosterone once SHBG binding and aromatization are factored in. Men with symptoms of inflammation and joint pain should always have their free testosterone, estradiol, SHBG, and CRP evaluated together - not just total testosterone in isolation.
Does Testosterone Therapy Actually Improve Inflammatory Markers and Joint Health?
The short answer is yes - at physiologic doses, TRT consistently demonstrates anti-inflammatory effects in the available evidence.In men with hypogonadism and rheumatoid arthritis, testosterone therapy has been shown to reduce joint tenderness, morning stiffness, and levels of the inflammatory cytokines TNF-alpha and IL-1-beta. These changes are not merely the result of feeling better; they reflect measurable shifts in immune cell behavior driven by androgen receptor signaling.
More recently, a landmark 2024 study published in Nature examined immune system changes in individuals undergoing gender-affirming testosterone therapy. The research found that testosterone modulates a cross-regulated axis between type-I interferon and tumor necrosis factor signaling - confirming that androgen-driven immune regulation is real, measurable, and occurs rapidly after testosterone levels rise.
In the context of TRT for hypogonadal men, many community members at ExcelMale.com report that their aches and chronic inflammation improved noticeably within the first months of treatment. This is consistent with what the research predicts: as testosterone levels normalize, the 5-LOX/FLAP suppression pathway is re-engaged, cytokine production falls, and the joint environment becomes less destructive.
It is worth noting that estradiol balance matters too. Testosterone alone does not protect joints - it must also aromatize adequately to estradiol to maintain cartilage proteoglycan production and synovial fluid health. Men who use aromatase inhibitors aggressively often develop worsening joint pain precisely because they remove the estradiol that testosterone was generating. The goal is hormonal balance, not suppression.
Frequently Asked Questions
Does testosterone suppress the immune system in a way that makes infections worse?
At physiologic levels, the immune-dampening effects of testosterone are modest and context-dependent. While men do tend to mount slightly lower initial antibody responses to vaccines and may have slower viral clearance, this is a normal feature of the male hormonal environment - not a pathological immune deficiency. The concern is more relevant at supraphysiologic doses (as used by bodybuilders), where significant immune suppression has been documented. Men on standard TRT protocols do not experience meaningful increases in infection risk.Can getting testosterone levels into optimal range reduce my arthritis symptoms?
Clinical evidence suggests yes, particularly for rheumatoid arthritis. Several studies have demonstrated reductions in joint tenderness, stiffness, and inflammatory cytokine levels following testosterone therapy in men with low testosterone and RA. For osteoarthritis, the evidence is more indirect - testosterone's bone-protective and cartilage-sustaining effects support joint health over the long term, but established OA damage is not fully reversible through hormonal optimization alone. Many men at ExcelMale.com report meaningful improvements in joint comfort within the first three to six months of achieving optimal testosterone levels.What blood tests should I run to evaluate my inflammation and testosterone status together?
A baseline panel for men concerned about hormonal and inflammatory health should include: total testosterone, free testosterone (calculated or equilibrium dialysis), SHBG, estradiol (sensitive assay), CRP (high-sensitivity), CBC, and a comprehensive metabolic panel. If joint pain is significant, adding ESR, uric acid, rheumatoid factor, and anti-CCP antibodies helps rule out autoimmune arthritis. DiscountedLabs.com offers cost-effective panels that cover most of these markers.Is it normal for joint pain to worsen temporarily when starting TRT?
Some men report a brief increase in joint aching in the early weeks of TRT. This can occur for several reasons: rapid changes in fluid retention, rising estradiol during the hormonal adjustment period, or a temporary shift in the inflammatory balance before the androgen system stabilizes. Most men find that any early joint changes resolve within four to eight weeks. Persistent or worsening joint pain after that window - particularly if associated with low estradiol - warrants a review of aromatase inhibitor dosing and an updated hormone panel.Why do doctors rarely discuss testosterone's role in immune function and arthritis?
Mainstream medicine has been slow to integrate hormonal immunology into rheumatology practice. Most rheumatologists are trained to manage autoimmune conditions with immunosuppressant medications and do not routinely test testosterone levels. The research connecting low testosterone to arthritis risk is relatively recent - the NHANES study was only published in 2023 - and it takes years for population-level findings to shift clinical practice guidelines. This is precisely why forums like ExcelMale.com serve an important role: they give men access to current evidence and practical experience that has not yet filtered down into the standard clinical encounter.Related ExcelMale Forum Discussions
• Investigating the Effects of Testosterone on the Human Immune System - Research discussion and video presentation by Dr. Camila Consiglio on how testosterone rewires immune signaling, including sex-based differences in vaccine response.
• How Testosterone Levels Impact Men's Immunity: New Research Uncovers Sex Differences in Infection and Cancer Risk - Forum thread reviewing 2025 research on testosterone, immune cell abundance, and differential disease susceptibility between men and women.
• Sex Hormone Signaling and Regulation of Immune Function - Deep-dive discussion on the molecular pathways through which sex hormones regulate innate and adaptive immunity, with links to peer-reviewed literature.
• Autoimmune Disease in Relation to Testosterone - Member experiences linking low testosterone to the onset and progression of autoimmune conditions, including Crohn's disease and inflammatory bowel disease.
• Does Testosterone Suppress the Immune System? - Classic ExcelMale thread examining whether TRT-level testosterone meaningfully suppresses immune function, with community perspectives and reference links.
• Why Does Low Estradiol Cause Joint Pain in Men on TRT? - Comprehensive guide explaining how aggressive aromatase inhibitor use strips cartilage-protective estradiol from TRT men, driving joint deterioration and elevated CRP.
• Does Low Estradiol Cause Joint Pain in Men Because of Inflammation? - Community thread with Nelson Vergel's input on the role of both low testosterone and low estradiol in driving CRP elevation and joint aching.
• TRT (Testosterone Replacement) and COVID-19 Vaccine - Member discussion on whether TRT affects vaccine immune responses, with references to androgen modulation of antibody production.
• Deca (Nandrolone) for Joint Pain - Community experiences using low-dose nandrolone as an adjunct for joint pain management in hypogonadal men, including safety and dosing considerations.
• Nagging, Persistent Joint Pain on TRT - Forum thread where members troubleshoot unexplained joint pain on TRT, including discussions of cortisol, inflammatory markers, and hormonal balance.
Key References
1. Cheng L, Wang S. Lower serum testosterone is associated with increased likelihood of arthritis. Scientific Reports. 2023;13:19033. Link
2. Consiglio CR, et al. Immune system adaptation during gender-affirming testosterone treatment. Nature. 2024. Link
3. Panevin TS, et al. Clinical and laboratory features of rheumatoid arthritis in men depending on testosterone levels. Problems of Endocrinology. 2023. Link
4. Poole JA, et al. Combined repetitive inhalant endotoxin and collagen-induced arthritis drive inflammatory lung disease and arthritis severity in a testosterone-dependent manner. Am J Physiol Lung Cell Mol Physiol. 2023. Link
5. Cutolo M, Straub RH. Sex steroids and autoimmune rheumatic diseases: state of the art. Nat Rev Rheumatol. 2020;16:628-644. Link
6. Liao Q, et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020;588:315-320. Link
7. Angele MK, et al. Testosterone and immune function. Critical Care Medicine. 2020. Link
8. Harding AT, Heaton NS. The impact of estrogens and their receptors on immunity and inflammation during infection. Cancers (Basel). 2022;14(4):909. Link
9. Pergola C, et al. Androgens suppress 5-lipoxygenase activation in polymorphonuclear leukocytes. FASEB J. 2011;25(8):2832-2842. Link
10. Capellino S, Claus M, Watzl C. Regulation of natural killer cell activity by glucocorticoids, sex hormones and prolactin. Endocr Connect. 2020;9(4):R19-R34. Link
Conclusion: Testosterone as a Systemic Anti-Inflammatory
The emerging picture from both population-level studies and mechanistic research is clear: testosterone is a fundamental regulator of immune balance and joint health, not merely a hormone for muscle and libido. At physiologic levels, it keeps the inflammatory machinery - specifically the 5-LOX/FLAP complex - from operating at full throttle, reducing leukotriene and cytokine production in a way that protects joints, suppresses autoimmune reactivity, and modulates the body's response to infections.For men with low testosterone, this regulatory function is impaired. Joints become more vulnerable to inflammatory destruction, the risk of rheumatoid arthritis rises dramatically, and the obesity-testosterone cycle can accelerate the entire process. Achieving and maintaining physiologically appropriate testosterone levels - not just "within reference range" but in the range where these anti-inflammatory effects are active - is a meaningful strategy for long-term musculoskeletal and immune health.
If you are dealing with joint pain, elevated CRP, or unexplained inflammation alongside symptoms of low testosterone, consider discussing a comprehensive hormone panel with your physician. For further reading, explore our guides on understanding your blood test results on TRT and SHBG: how it controls free testosterone and what to do about it.
Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting or modifying any hormone therapy or medical treatment. Individual results vary and depend on many factors including baseline health, co-existing conditions, and specific treatment protocols.
About ExcelMale.com
ExcelMale.com is the most trusted, expert-moderated men's health community on the internet, with over 24,000 members and more than 20 years of archived discussions on testosterone replacement therapy, hormone optimization, peptides, sexual health, and longevity. Founded by Nelson Vergel - chemical engineer, 34+ year TRT patient, and patient advocate - ExcelMale bridges the gap between clinical research and real-world male health. Nelson is the author of
Testosterone: A Man's Guide and Beyond Testosterone, both available on Amazon. Visit ExcelMale.com to join the community, access free hormone calculators, and find a TRT-knowledgeable physician through our doctor finder.
